Intratumoral delivery of tumor antigen-loaded DC and tumor-primed CD4+ T cells combined with agonist α-GITR mAb promotes durable CD8+ T-cell-dependent antitumor immunity-Reference-Cited by-同舟云学术

Intratumoral delivery of tumor antigen-loaded DC and tumor-primed CD4+ T cells combined with agonist α-GITR mAb promotes durable CD8+ T-cell-dependent antitumor immunity

Published:2017-05-19 Issue:6 Volume:6 Page:
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Liu Zuqiang¹²³^ORCID,Hao Xingxing¹^ORCID,Zhang Yi¹⁴,Zhang Jiying¹,Carey Cara D.¹,Falo Louis D.¹³,Storkus Walter J.¹³⁵,You Zhaoyang¹³⁵

Affiliation:

1. Department of Dermatology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA

2. Department of Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA

3. University of Pittsburgh Cancer Institute, Pittsburgh, PA, USA

4. The 3rd Affiliated Hospital of Jianghan University, Wuhan, Hubei, China

5. Department of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2017.1315487

Reference65 articles.

1. Failure at the Effector Phase: Immune Barriers at the Level of the Melanoma Tumor Microenvironment

2. T cell exclusion, immune privilege, and the tumor microenvironment

3. Vascular targeting, chemotherapy and active immunotherapy: teaming up to attack cancer

4. Enhancing Cancer Vaccine Efficacy via Modulation of the Tumor Microenvironment

5. Targeting the tumor microenvironment: removing obstruction to anticancer immune responses and immunotherapy

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in Therapeutic Targeting of the Tumor Necrosis Factor Receptor Superfamily Members for Cancer Immunotherapy;Handbook of Cancer and Immunology;2023

2. Clinical Research on the Mechanisms Underlying Immune Checkpoints and Tumor Metastasis;Frontiers in Oncology;2021-07-22

3. Skin immunization for effective treatment of multifocal melanoma refractory to PD1 blockade and Braf inhibitors;Journal for ImmunoTherapy of Cancer;2021-01

4. Novel HLA-A2 restricted antigenic peptide derivatives with high affinity for the treatment of breast cancer expressing NY-ESO-1;Bioorganic Chemistry;2020-10

5. New directions in chimeric antigen receptor T cell [CAR‐T] therapy and related flow cytometry;Cytometry Part B: Clinical Cytometry;2020-04-30